Sort
30,917 grants matching “tumor microenvironment”
Intervention of immune tolerance by small molecules to enhance immune therapy
$349,982Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$349,981Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2022 · CA
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$349,968Marxa L. Figueiredo · Purdue University · R01 · FY2018 · CA
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
$349,954Theresa A Guise · University Of Virginia · R01 · FY2006 · DK
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy
$349,947Jessica E Thaxton · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
In vivo monitoring of tumor microenvironment regulation by macrophages
$349,940Valery V Khramtsov · West Virginia University · R01 · FY2016 · CA
Separating autoimmunity and anti-tumor immunity
$349,910Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2019 · CA
Bone-Targeted Therapies to Improve Bone Health and Prevent Relapse in Multiple Myeloma
$349,898Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R37 · FY2022 · CA
Early phase clinical trial for imaging tumor acidosis in breast cancer patients using acidoCEST MRI
$349,892Mark David Pagel · University Of Arizona · R01 · FY2015 · CA
Modeling and targeting tumor-immune signaling interactions in tumor microenvironment
$349,875Fuhai Li · Washington University · R01 · FY2024 · LM
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$349,875Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2025 · NS
Modeling and targeting tumor-immune signaling interactions in tumor microenvironment
$349,874Fuhai Li · Washington University · R01 · FY2025 · LM
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$349,874Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
$349,874Saori Furuta · Case Western Reserve University · R01 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$349,813William E Gillanders · Washington University · U2C · FY2023 · CA
Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation
$349,811Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
$349,808Benjamin Izar · Columbia University Health Sciences · U54 · FY2024 · CA
Development of a multifunctional, acoustofluidic 3D bioprinter with single-cell resolution
$349,781Zhenhua Tian · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · GM
CD200R signaling in tumor growth, immunity and immunotherapy
$349,713Sujit Basu · Ohio State University · R01 · FY2022 · CA
IL-27 as a potential immunotherapeutic for cancer
$349,713Sujit Basu · Ohio State University · R01 · FY2022 · CA
(11) Diet Modification to Augment Radiation for Breast Cancer Brain Metastases
$349,713Nicole L Simone · Thomas Jefferson University · R01 · FY2022 · CA
Drivers of metabolic plasticity promote radiation resistance in glioblastoma multiforme
$349,713Erina Vlashi · University Of California Los Angeles · R01 · FY2023 · CA
IL-27 as a potential immunotherapeutic for cancer
$349,713Sujit Basu · Ohio State University · R01 · FY2023 · CA
Drivers of metabolic plasticity promote radiation resistance in glioblastoma multiforme
$349,713Erina Vlashi · University Of California Los Angeles · R01 · FY2022 · CA
Tissue Damage-Driven Squamous Cell Carcinoma
$349,713Andrew South · Thomas Jefferson University · R01 · FY2022 · CA